Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (tablet) from SpecGx LLC with status Current. The shortage was first posted on 10/12/2022. Reported reason: Demand increase for the drug
Shortage Details
- Status
- Current
- Company
- SpecGx LLC
- Package NDC
- 0406-8884-01
- Dosage Form
- Tablet
- Presentation
- Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01)
- Initial Posting
- 10/12/2022
- Revised Date
Reason
Demand increase for the drug